nodes	percent_of_prediction	percent_of_DWPC	metapath
Repaglinide—type 2 diabetes mellitus—obesity	0.516	1	CtDrD
Repaglinide—PPARG—obesity	0.159	0.727	CbGaD
Repaglinide—ALB—obesity	0.0596	0.273	CbGaD
Repaglinide—CYP2C8—Bupropion—obesity	0.0298	0.246	CbGbCtD
Repaglinide—CYP2C8—Cimetidine—obesity	0.0218	0.18	CbGbCtD
Repaglinide—CYP3A4—Sibutramine—obesity	0.0187	0.155	CbGbCtD
Repaglinide—CYP3A4—Benzphetamine—obesity	0.0142	0.117	CbGbCtD
Repaglinide—CYP3A4—Bupropion—obesity	0.0121	0.0997	CbGbCtD
Repaglinide—CYP3A4—Orlistat—obesity	0.00984	0.0813	CbGbCtD
Repaglinide—CYP3A4—Cimetidine—obesity	0.00886	0.0732	CbGbCtD
Repaglinide—CYP3A4—Topiramate—obesity	0.0058	0.0479	CbGbCtD
Repaglinide—PPARG—brown adipose tissue—obesity	0.00276	0.193	CbGeAlD
Repaglinide—ALB—gall bladder—obesity	0.000835	0.0584	CbGeAlD
Repaglinide—KCNJ11—islet of Langerhans—obesity	0.00083	0.058	CbGeAlD
Repaglinide—ABCC8—islet of Langerhans—obesity	0.000764	0.0534	CbGeAlD
Repaglinide—KCNJ11—cardiovascular system—obesity	0.0006	0.0419	CbGeAlD
Repaglinide—PPARG—islet of Langerhans—obesity	0.000583	0.0408	CbGeAlD
Repaglinide—ABCC8—cardiovascular system—obesity	0.000553	0.0386	CbGeAlD
Repaglinide—PPARG—respiratory system—obesity	0.000551	0.0385	CbGeAlD
Repaglinide—ABCC8—pituitary gland—obesity	0.000489	0.0342	CbGeAlD
Repaglinide—KCNJ11—adrenal gland—obesity	0.000475	0.0332	CbGeAlD
Repaglinide—Gastrointestinal disorder—Methamphetamine—obesity	0.000463	0.00733	CcSEcCtD
Repaglinide—Constipation—Methamphetamine—obesity	0.000458	0.00726	CcSEcCtD
Repaglinide—Dyspepsia—Benzphetamine—obesity	0.000455	0.00721	CcSEcCtD
Repaglinide—Hepatitis—Cimetidine—obesity	0.000449	0.00711	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Benzphetamine—obesity	0.000446	0.00707	CcSEcCtD
Repaglinide—Hepatic enzyme increased—Bupropion—obesity	0.00044	0.00697	CcSEcCtD
Repaglinide—ABCC8—adrenal gland—obesity	0.000437	0.0306	CbGeAlD
Repaglinide—Urticaria—Methamphetamine—obesity	0.000426	0.00675	CcSEcCtD
Repaglinide—Erythema multiforme—Cimetidine—obesity	0.000424	0.00672	CcSEcCtD
Repaglinide—PPARG—cardiovascular system—obesity	0.000422	0.0295	CbGeAlD
Repaglinide—Arrhythmia—Diethylpropion—obesity	0.000421	0.00667	CcSEcCtD
Repaglinide—Palpitations—Phentermine—obesity	0.000417	0.00661	CcSEcCtD
Repaglinide—Alopecia—Diethylpropion—obesity	0.000417	0.0066	CcSEcCtD
Repaglinide—KCNJ11—endocrine gland—obesity	0.000412	0.0288	CbGeAlD
Repaglinide—Urticaria—Benzphetamine—obesity	0.00041	0.0065	CcSEcCtD
Repaglinide—Erythema—Diethylpropion—obesity	0.00041	0.0065	CcSEcCtD
Repaglinide—Tooth disorder—Topiramate—obesity	0.000409	0.00648	CcSEcCtD
Repaglinide—Hypertension—Phentermine—obesity	0.000407	0.00645	CcSEcCtD
Repaglinide—SLCO1B1—digestive system—obesity	0.000406	0.0284	CbGeAlD
Repaglinide—Electrocardiogram abnormal—Topiramate—obesity	0.000405	0.00641	CcSEcCtD
Repaglinide—Constipation—Phendimetrazine—obesity	0.000403	0.00638	CcSEcCtD
Repaglinide—Chest pain—Phentermine—obesity	0.000402	0.00636	CcSEcCtD
Repaglinide—Hepatic function abnormal—Sibutramine—obesity	0.000396	0.00628	CcSEcCtD
Repaglinide—Alopecia—Cimetidine—obesity	0.000396	0.00628	CcSEcCtD
Repaglinide—Hypersensitivity—Methamphetamine—obesity	0.000395	0.00626	CcSEcCtD
Repaglinide—Oedema—Phentermine—obesity	0.000385	0.0061	CcSEcCtD
Repaglinide—Cardiac failure congestive—Sibutramine—obesity	0.000382	0.00605	CcSEcCtD
Repaglinide—Hypersensitivity—Benzphetamine—obesity	0.000381	0.00603	CcSEcCtD
Repaglinide—ABCC8—endocrine gland—obesity	0.000379	0.0265	CbGeAlD
Repaglinide—Abdominal pain—Phendimetrazine—obesity	0.000372	0.0059	CcSEcCtD
Repaglinide—PPARG—adipose tissue—obesity	0.000372	0.026	CbGeAlD
Repaglinide—Leukopenia—Diethylpropion—obesity	0.000367	0.00582	CcSEcCtD
Repaglinide—Hypoglycaemia—Orlistat—obesity	0.000367	0.00581	CcSEcCtD
Repaglinide—Diarrhoea—Methamphetamine—obesity	0.000367	0.00581	CcSEcCtD
Repaglinide—Palpitations—Diethylpropion—obesity	0.000363	0.00575	CcSEcCtD
Repaglinide—Anaphylactoid reaction—Sibutramine—obesity	0.000358	0.00567	CcSEcCtD
Repaglinide—Hypoglycaemia—Sibutramine—obesity	0.000355	0.00562	CcSEcCtD
Repaglinide—Diarrhoea—Benzphetamine—obesity	0.000354	0.0056	CcSEcCtD
Repaglinide—PPARG—digestive system—obesity	0.00035	0.0245	CbGeAlD
Repaglinide—Leukopenia—Cimetidine—obesity	0.000349	0.00554	CcSEcCtD
Repaglinide—Chest pain—Diethylpropion—obesity	0.000349	0.00554	CcSEcCtD
Repaglinide—Hepatic function abnormal—Bupropion—obesity	0.000346	0.00548	CcSEcCtD
Repaglinide—Constipation—Phenylpropanolamine—obesity	0.000344	0.00545	CcSEcCtD
Repaglinide—Dyspepsia—Phentermine—obesity	0.000339	0.00537	CcSEcCtD
Repaglinide—Headache—Methamphetamine—obesity	0.000336	0.00532	CcSEcCtD
Repaglinide—SLCO1B1—endocrine gland—obesity	0.000336	0.0235	CbGeAlD
Repaglinide—PPARG—adrenal gland—obesity	0.000334	0.0233	CbGeAlD
Repaglinide—Arthralgia—Cimetidine—obesity	0.000332	0.00527	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Phentermine—obesity	0.000332	0.00527	CcSEcCtD
Repaglinide—Constipation—Phentermine—obesity	0.000329	0.00522	CcSEcCtD
Repaglinide—Headache—Benzphetamine—obesity	0.000324	0.00513	CcSEcCtD
Repaglinide—Diarrhoea—Phendimetrazine—obesity	0.000322	0.00511	CcSEcCtD
Repaglinide—Visual disturbance—Bupropion—obesity	0.000319	0.00505	CcSEcCtD
Repaglinide—Anaphylactic shock—Cimetidine—obesity	0.000319	0.00505	CcSEcCtD
Repaglinide—ALB—adrenal gland—obesity	0.000313	0.0219	CbGeAlD
Repaglinide—Thrombocytopenia—Cimetidine—obesity	0.000312	0.00494	CcSEcCtD
Repaglinide—Hypoglycaemia—Bupropion—obesity	0.000309	0.0049	CcSEcCtD
Repaglinide—Nausea—Benzphetamine—obesity	0.000307	0.00486	CcSEcCtD
Repaglinide—Urticaria—Phentermine—obesity	0.000306	0.00485	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Diethylpropion—obesity	0.000305	0.00484	CcSEcCtD
Repaglinide—Abdominal pain—Phentermine—obesity	0.000304	0.00482	CcSEcCtD
Repaglinide—Pancreatitis—Orlistat—obesity	0.000303	0.00481	CcSEcCtD
Repaglinide—SLCO1B1—liver—obesity	0.000303	0.0211	CbGeAlD
Repaglinide—Cardiovascular disorder—Topiramate—obesity	0.000302	0.00478	CcSEcCtD
Repaglinide—Hypersensitivity—Phenylpropanolamine—obesity	0.000296	0.0047	CcSEcCtD
Repaglinide—Headache—Phendimetrazine—obesity	0.000295	0.00468	CcSEcCtD
Repaglinide—Dyspepsia—Diethylpropion—obesity	0.000295	0.00467	CcSEcCtD
Repaglinide—Angina pectoris—Sibutramine—obesity	0.000292	0.00462	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Cimetidine—obesity	0.00029	0.0046	CcSEcCtD
Repaglinide—PPARG—endocrine gland—obesity	0.000289	0.0202	CbGeAlD
Repaglinide—Gastrointestinal disorder—Diethylpropion—obesity	0.000289	0.00458	CcSEcCtD
Repaglinide—Bronchitis—Sibutramine—obesity	0.000288	0.00456	CcSEcCtD
Repaglinide—Constipation—Diethylpropion—obesity	0.000286	0.00454	CcSEcCtD
Repaglinide—Hepatic enzyme increased—Topiramate—obesity	0.00028	0.00444	CcSEcCtD
Repaglinide—Nausea—Phendimetrazine—obesity	0.00028	0.00443	CcSEcCtD
Repaglinide—Constipation—Cimetidine—obesity	0.000272	0.00432	CcSEcCtD
Repaglinide—Hyperglycaemia—Sibutramine—obesity	0.00027	0.00428	CcSEcCtD
Repaglinide—Urinary tract infection—Orlistat—obesity	0.000268	0.00425	CcSEcCtD
Repaglinide—Urticaria—Diethylpropion—obesity	0.000266	0.00422	CcSEcCtD
Repaglinide—Diarrhoea—Phentermine—obesity	0.000263	0.00417	CcSEcCtD
Repaglinide—Acute coronary syndrome—Sibutramine—obesity	0.000263	0.00417	CcSEcCtD
Repaglinide—Myocardial infarction—Sibutramine—obesity	0.000262	0.00415	CcSEcCtD
Repaglinide—PPARG—liver—obesity	0.000261	0.0182	CbGeAlD
Repaglinide—Hepatobiliary disease—Orlistat—obesity	0.000261	0.00413	CcSEcCtD
Repaglinide—Urinary tract infection—Sibutramine—obesity	0.000259	0.00411	CcSEcCtD
Repaglinide—Sinusitis—Orlistat—obesity	0.000259	0.0041	CcSEcCtD
Repaglinide—Pancreatitis—Bupropion—obesity	0.000256	0.00406	CcSEcCtD
Repaglinide—Vomiting—Phenylpropanolamine—obesity	0.000256	0.00405	CcSEcCtD
Repaglinide—Rash—Phenylpropanolamine—obesity	0.000254	0.00402	CcSEcCtD
Repaglinide—Dermatitis—Phenylpropanolamine—obesity	0.000253	0.00402	CcSEcCtD
Repaglinide—Bronchitis—Bupropion—obesity	0.000251	0.00398	CcSEcCtD
Repaglinide—Sinusitis—Sibutramine—obesity	0.00025	0.00397	CcSEcCtD
Repaglinide—Hepatitis—Orlistat—obesity	0.000248	0.00392	CcSEcCtD
Repaglinide—CYP2C8—pituitary gland—obesity	0.000246	0.0172	CbGeAlD
Repaglinide—ALB—liver—obesity	0.000245	0.0171	CbGeAlD
Repaglinide—Vomiting—Phentermine—obesity	0.000245	0.00388	CcSEcCtD
Repaglinide—Oedema peripheral—Orlistat—obesity	0.000244	0.00387	CcSEcCtD
Repaglinide—Rash—Phentermine—obesity	0.000243	0.00385	CcSEcCtD
Repaglinide—Dermatitis—Phentermine—obesity	0.000243	0.00384	CcSEcCtD
Repaglinide—Headache—Phentermine—obesity	0.000241	0.00382	CcSEcCtD
Repaglinide—Rhinitis—Sibutramine—obesity	0.00024	0.00381	CcSEcCtD
Repaglinide—Nausea—Phenylpropanolamine—obesity	0.000239	0.00379	CcSEcCtD
Repaglinide—Oedema peripheral—Sibutramine—obesity	0.000236	0.00374	CcSEcCtD
Repaglinide—Hyperglycaemia—Bupropion—obesity	0.000235	0.00373	CcSEcCtD
Repaglinide—Hypersensitivity—Cimetidine—obesity	0.000235	0.00372	CcSEcCtD
Repaglinide—Visual impairment—Sibutramine—obesity	0.000231	0.00366	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Bupropion—obesity	0.000231	0.00366	CcSEcCtD
Repaglinide—Acute coronary syndrome—Bupropion—obesity	0.000229	0.00364	CcSEcCtD
Repaglinide—Diarrhoea—Diethylpropion—obesity	0.000229	0.00363	CcSEcCtD
Repaglinide—Nausea—Phentermine—obesity	0.000229	0.00362	CcSEcCtD
Repaglinide—Myocardial infarction—Bupropion—obesity	0.000228	0.00361	CcSEcCtD
Repaglinide—Jaundice—Bupropion—obesity	0.000227	0.00359	CcSEcCtD
Repaglinide—Urinary tract infection—Bupropion—obesity	0.000226	0.00358	CcSEcCtD
Repaglinide—Eye disorder—Sibutramine—obesity	0.000224	0.00355	CcSEcCtD
Repaglinide—Immune system disorder—Orlistat—obesity	0.000224	0.00354	CcSEcCtD
Repaglinide—Alopecia—Orlistat—obesity	0.000219	0.00347	CcSEcCtD
Repaglinide—Sinusitis—Bupropion—obesity	0.000218	0.00346	CcSEcCtD
Repaglinide—Diarrhoea—Cimetidine—obesity	0.000218	0.00345	CcSEcCtD
Repaglinide—Immune system disorder—Sibutramine—obesity	0.000216	0.00343	CcSEcCtD
Repaglinide—Malnutrition—Orlistat—obesity	0.000216	0.00342	CcSEcCtD
Repaglinide—Arrhythmia—Sibutramine—obesity	0.000214	0.00339	CcSEcCtD
Repaglinide—Vomiting—Diethylpropion—obesity	0.000213	0.00337	CcSEcCtD
Repaglinide—Alopecia—Sibutramine—obesity	0.000212	0.00336	CcSEcCtD
Repaglinide—Rash—Diethylpropion—obesity	0.000211	0.00335	CcSEcCtD
Repaglinide—Dermatitis—Diethylpropion—obesity	0.000211	0.00334	CcSEcCtD
Repaglinide—Headache—Diethylpropion—obesity	0.00021	0.00332	CcSEcCtD
Repaglinide—Rhinitis—Bupropion—obesity	0.000209	0.00332	CcSEcCtD
Repaglinide—Hepatitis—Bupropion—obesity	0.000209	0.00331	CcSEcCtD
Repaglinide—Malnutrition—Sibutramine—obesity	0.000209	0.00331	CcSEcCtD
Repaglinide—Back pain—Orlistat—obesity	0.000209	0.0033	CcSEcCtD
Repaglinide—Oedema peripheral—Bupropion—obesity	0.000206	0.00326	CcSEcCtD
Repaglinide—Visual disturbance—Topiramate—obesity	0.000203	0.00322	CcSEcCtD
Repaglinide—Vomiting—Cimetidine—obesity	0.000203	0.00321	CcSEcCtD
Repaglinide—Back pain—Sibutramine—obesity	0.000202	0.0032	CcSEcCtD
Repaglinide—Visual impairment—Bupropion—obesity	0.000201	0.00319	CcSEcCtD
Repaglinide—Rash—Cimetidine—obesity	0.000201	0.00318	CcSEcCtD
Repaglinide—Dermatitis—Cimetidine—obesity	0.000201	0.00318	CcSEcCtD
Repaglinide—Headache—Cimetidine—obesity	0.0002	0.00316	CcSEcCtD
Repaglinide—Nausea—Diethylpropion—obesity	0.000199	0.00315	CcSEcCtD
Repaglinide—Erythema multiforme—Bupropion—obesity	0.000198	0.00313	CcSEcCtD
Repaglinide—Hypoglycaemia—Topiramate—obesity	0.000197	0.00312	CcSEcCtD
Repaglinide—Eye disorder—Bupropion—obesity	0.000195	0.00309	CcSEcCtD
Repaglinide—Cardiac disorder—Bupropion—obesity	0.000194	0.00307	CcSEcCtD
Repaglinide—CYP2C8—endocrine gland—obesity	0.000191	0.0133	CbGeAlD
Repaglinide—Palpitations—Orlistat—obesity	0.00019	0.00302	CcSEcCtD
Repaglinide—Nausea—Cimetidine—obesity	0.000189	0.003	CcSEcCtD
Repaglinide—Immune system disorder—Bupropion—obesity	0.000189	0.00299	CcSEcCtD
Repaglinide—Leukopenia—Sibutramine—obesity	0.000187	0.00296	CcSEcCtD
Repaglinide—Arrhythmia—Bupropion—obesity	0.000187	0.00296	CcSEcCtD
Repaglinide—Alopecia—Bupropion—obesity	0.000185	0.00293	CcSEcCtD
Repaglinide—Palpitations—Sibutramine—obesity	0.000184	0.00292	CcSEcCtD
Repaglinide—Chest pain—Orlistat—obesity	0.000184	0.00291	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000182	0.00289	CcSEcCtD
Repaglinide—Malnutrition—Bupropion—obesity	0.000182	0.00288	CcSEcCtD
Repaglinide—Hypertension—Sibutramine—obesity	0.00018	0.00285	CcSEcCtD
Repaglinide—Chest pain—Sibutramine—obesity	0.000178	0.00281	CcSEcCtD
Repaglinide—Arthralgia—Sibutramine—obesity	0.000178	0.00281	CcSEcCtD
Repaglinide—Anaphylactic shock—Orlistat—obesity	0.000176	0.00279	CcSEcCtD
Repaglinide—Oedema—Orlistat—obesity	0.000176	0.00279	CcSEcCtD
Repaglinide—Back pain—Bupropion—obesity	0.000176	0.00279	CcSEcCtD
Repaglinide—CYP2C8—liver—obesity	0.000172	0.012	CbGeAlD
Repaglinide—Skin disorder—Orlistat—obesity	0.000171	0.00271	CcSEcCtD
Repaglinide—Anaphylactic shock—Sibutramine—obesity	0.00017	0.0027	CcSEcCtD
Repaglinide—Oedema—Sibutramine—obesity	0.00017	0.0027	CcSEcCtD
Repaglinide—Thrombocytopenia—Sibutramine—obesity	0.000167	0.00264	CcSEcCtD
Repaglinide—Skin disorder—Sibutramine—obesity	0.000165	0.00262	CcSEcCtD
Repaglinide—Pancreatitis—Topiramate—obesity	0.000163	0.00258	CcSEcCtD
Repaglinide—Leukopenia—Bupropion—obesity	0.000163	0.00258	CcSEcCtD
Repaglinide—Angina pectoris—Topiramate—obesity	0.000162	0.00257	CcSEcCtD
Repaglinide—Palpitations—Bupropion—obesity	0.000161	0.00255	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Orlistat—obesity	0.00016	0.00254	CcSEcCtD
Repaglinide—Bronchitis—Topiramate—obesity	0.00016	0.00253	CcSEcCtD
Repaglinide—Paraesthesia—Orlistat—obesity	0.000158	0.0025	CcSEcCtD
Repaglinide—Hypertension—Bupropion—obesity	0.000157	0.00249	CcSEcCtD
Repaglinide—CYP3A4—digestive system—obesity	0.000156	0.0109	CbGeAlD
Repaglinide—Musculoskeletal discomfort—Sibutramine—obesity	0.000155	0.00246	CcSEcCtD
Repaglinide—Dyspepsia—Orlistat—obesity	0.000155	0.00245	CcSEcCtD
Repaglinide—Arthralgia—Bupropion—obesity	0.000155	0.00245	CcSEcCtD
Repaglinide—Chest pain—Bupropion—obesity	0.000155	0.00245	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000154	0.00244	CcSEcCtD
Repaglinide—Paraesthesia—Sibutramine—obesity	0.000153	0.00242	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Orlistat—obesity	0.000152	0.00241	CcSEcCtD
Repaglinide—Hyperglycaemia—Topiramate—obesity	0.00015	0.00238	CcSEcCtD
Repaglinide—Dyspepsia—Sibutramine—obesity	0.00015	0.00237	CcSEcCtD
Repaglinide—Oedema—Bupropion—obesity	0.000148	0.00235	CcSEcCtD
Repaglinide—Anaphylactic shock—Bupropion—obesity	0.000148	0.00235	CcSEcCtD
Repaglinide—Stevens-Johnson syndrome—Topiramate—obesity	0.000147	0.00233	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Sibutramine—obesity	0.000147	0.00233	CcSEcCtD
Repaglinide—Constipation—Sibutramine—obesity	0.000146	0.00231	CcSEcCtD
Repaglinide—Thrombocytopenia—Bupropion—obesity	0.000145	0.0023	CcSEcCtD
Repaglinide—Skin disorder—Bupropion—obesity	0.000144	0.00228	CcSEcCtD
Repaglinide—Urinary tract infection—Topiramate—obesity	0.000144	0.00228	CcSEcCtD
Repaglinide—Gastrointestinal pain—Orlistat—obesity	0.000144	0.00228	CcSEcCtD
Repaglinide—Urticaria—Orlistat—obesity	0.00014	0.00221	CcSEcCtD
Repaglinide—Gastrointestinal pain—Sibutramine—obesity	0.000139	0.00221	CcSEcCtD
Repaglinide—Sinusitis—Topiramate—obesity	0.000139	0.0022	CcSEcCtD
Repaglinide—Abdominal pain—Orlistat—obesity	0.000139	0.0022	CcSEcCtD
Repaglinide—Urticaria—Sibutramine—obesity	0.000135	0.00214	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Bupropion—obesity	0.000135	0.00214	CcSEcCtD
Repaglinide—Abdominal pain—Sibutramine—obesity	0.000135	0.00213	CcSEcCtD
Repaglinide—Rhinitis—Topiramate—obesity	0.000133	0.00211	CcSEcCtD
Repaglinide—Paraesthesia—Bupropion—obesity	0.000133	0.00211	CcSEcCtD
Repaglinide—Hepatitis—Topiramate—obesity	0.000133	0.00211	CcSEcCtD
Repaglinide—Oedema peripheral—Topiramate—obesity	0.000131	0.00208	CcSEcCtD
Repaglinide—Dyspepsia—Bupropion—obesity	0.000131	0.00207	CcSEcCtD
Repaglinide—Hypersensitivity—Orlistat—obesity	0.00013	0.00205	CcSEcCtD
Repaglinide—CYP3A4—endocrine gland—obesity	0.000129	0.00903	CbGeAlD
Repaglinide—Visual impairment—Topiramate—obesity	0.000128	0.00203	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Bupropion—obesity	0.000128	0.00203	CcSEcCtD
Repaglinide—Constipation—Bupropion—obesity	0.000127	0.00201	CcSEcCtD
Repaglinide—Erythema multiforme—Topiramate—obesity	0.000126	0.00199	CcSEcCtD
Repaglinide—Hypersensitivity—Sibutramine—obesity	0.000125	0.00199	CcSEcCtD
Repaglinide—Pruritus—Orlistat—obesity	0.000124	0.00197	CcSEcCtD
Repaglinide—Eye disorder—Topiramate—obesity	0.000124	0.00197	CcSEcCtD
Repaglinide—Cardiac disorder—Topiramate—obesity	0.000124	0.00196	CcSEcCtD
Repaglinide—Gastrointestinal pain—Bupropion—obesity	0.000121	0.00192	CcSEcCtD
Repaglinide—Pruritus—Sibutramine—obesity	0.00012	0.00191	CcSEcCtD
Repaglinide—Diarrhoea—Orlistat—obesity	0.00012	0.00191	CcSEcCtD
Repaglinide—Immune system disorder—Topiramate—obesity	0.00012	0.00191	CcSEcCtD
Repaglinide—Urticaria—Bupropion—obesity	0.000118	0.00187	CcSEcCtD
Repaglinide—Alopecia—Topiramate—obesity	0.000118	0.00186	CcSEcCtD
Repaglinide—Abdominal pain—Bupropion—obesity	0.000117	0.00186	CcSEcCtD
Repaglinide—CYP3A4—liver—obesity	0.000117	0.00814	CbGeAlD
Repaglinide—Diarrhoea—Sibutramine—obesity	0.000116	0.00185	CcSEcCtD
Repaglinide—Malnutrition—Topiramate—obesity	0.000116	0.00184	CcSEcCtD
Repaglinide—Erythema—Topiramate—obesity	0.000116	0.00184	CcSEcCtD
Repaglinide—Back pain—Topiramate—obesity	0.000112	0.00178	CcSEcCtD
Repaglinide—Vomiting—Orlistat—obesity	0.000112	0.00177	CcSEcCtD
Repaglinide—Rash—Orlistat—obesity	0.000111	0.00176	CcSEcCtD
Repaglinide—Dermatitis—Orlistat—obesity	0.000111	0.00176	CcSEcCtD
Repaglinide—Headache—Orlistat—obesity	0.00011	0.00175	CcSEcCtD
Repaglinide—Hypersensitivity—Bupropion—obesity	0.000109	0.00173	CcSEcCtD
Repaglinide—Vomiting—Sibutramine—obesity	0.000108	0.00172	CcSEcCtD
Repaglinide—Rash—Sibutramine—obesity	0.000107	0.0017	CcSEcCtD
Repaglinide—Dermatitis—Sibutramine—obesity	0.000107	0.0017	CcSEcCtD
Repaglinide—Headache—Sibutramine—obesity	0.000107	0.00169	CcSEcCtD
Repaglinide—Pruritus—Bupropion—obesity	0.000105	0.00166	CcSEcCtD
Repaglinide—Nausea—Orlistat—obesity	0.000104	0.00166	CcSEcCtD
Repaglinide—Leukopenia—Topiramate—obesity	0.000104	0.00164	CcSEcCtD
Repaglinide—Palpitations—Topiramate—obesity	0.000102	0.00162	CcSEcCtD
Repaglinide—Diarrhoea—Bupropion—obesity	0.000102	0.00161	CcSEcCtD
Repaglinide—Nausea—Sibutramine—obesity	0.000101	0.0016	CcSEcCtD
Repaglinide—Hypertension—Topiramate—obesity	0.0001	0.00159	CcSEcCtD
Repaglinide—Arthralgia—Topiramate—obesity	9.86e-05	0.00156	CcSEcCtD
Repaglinide—Chest pain—Topiramate—obesity	9.86e-05	0.00156	CcSEcCtD
Repaglinide—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	9.8e-05	0.00155	CcSEcCtD
Repaglinide—Oedema—Topiramate—obesity	9.46e-05	0.0015	CcSEcCtD
Repaglinide—Vomiting—Bupropion—obesity	9.44e-05	0.0015	CcSEcCtD
Repaglinide—Rash—Bupropion—obesity	9.36e-05	0.00148	CcSEcCtD
Repaglinide—Dermatitis—Bupropion—obesity	9.35e-05	0.00148	CcSEcCtD
Repaglinide—Headache—Bupropion—obesity	9.3e-05	0.00147	CcSEcCtD
Repaglinide—Thrombocytopenia—Topiramate—obesity	9.26e-05	0.00147	CcSEcCtD
Repaglinide—Skin disorder—Topiramate—obesity	9.19e-05	0.00146	CcSEcCtD
Repaglinide—Nausea—Bupropion—obesity	8.82e-05	0.0014	CcSEcCtD
Repaglinide—Musculoskeletal discomfort—Topiramate—obesity	8.62e-05	0.00137	CcSEcCtD
Repaglinide—Paraesthesia—Topiramate—obesity	8.49e-05	0.00135	CcSEcCtD
Repaglinide—Dyspepsia—Topiramate—obesity	8.32e-05	0.00132	CcSEcCtD
Repaglinide—Gastrointestinal disorder—Topiramate—obesity	8.16e-05	0.00129	CcSEcCtD
Repaglinide—Constipation—Topiramate—obesity	8.09e-05	0.00128	CcSEcCtD
Repaglinide—Gastrointestinal pain—Topiramate—obesity	7.73e-05	0.00123	CcSEcCtD
Repaglinide—Urticaria—Topiramate—obesity	7.51e-05	0.00119	CcSEcCtD
Repaglinide—Abdominal pain—Topiramate—obesity	7.48e-05	0.00118	CcSEcCtD
Repaglinide—Hypersensitivity—Topiramate—obesity	6.97e-05	0.0011	CcSEcCtD
Repaglinide—Pruritus—Topiramate—obesity	6.69e-05	0.00106	CcSEcCtD
Repaglinide—Diarrhoea—Topiramate—obesity	6.47e-05	0.00103	CcSEcCtD
Repaglinide—Vomiting—Topiramate—obesity	6.01e-05	0.000953	CcSEcCtD
Repaglinide—Rash—Topiramate—obesity	5.96e-05	0.000945	CcSEcCtD
Repaglinide—Dermatitis—Topiramate—obesity	5.96e-05	0.000944	CcSEcCtD
Repaglinide—Headache—Topiramate—obesity	5.92e-05	0.000939	CcSEcCtD
Repaglinide—Nausea—Topiramate—obesity	5.62e-05	0.00089	CcSEcCtD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PPARG—obesity	3.74e-06	5.51e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—LIPC—obesity	3.74e-06	5.51e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GCK—obesity	3.74e-06	5.51e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CD—obesity	3.72e-06	5.49e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PPARG—obesity	3.72e-06	5.48e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GCK—obesity	3.71e-06	5.48e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—LIPC—obesity	3.71e-06	5.48e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOC3—obesity	3.71e-06	5.48e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOC3—obesity	3.69e-06	5.45e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—POMC—obesity	3.69e-06	5.44e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ANGPTL4—obesity	3.68e-06	5.43e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SAT1—obesity	3.68e-06	5.43e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PNPLA2—obesity	3.68e-06	5.43e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PFKFB3—obesity	3.68e-06	5.43e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ACADM—obesity	3.68e-06	5.43e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PLIN1—obesity	3.68e-06	5.43e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—SERPINE1—obesity	3.68e-06	5.43e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—POMC—obesity	3.66e-06	5.41e-05	CbGpPWpGaD
Repaglinide—PPARG—Developmental Biology—AKT1—obesity	3.66e-06	5.4e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—POMC—obesity	3.63e-06	5.35e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—INS—obesity	3.61e-06	5.32e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CETP—obesity	3.6e-06	5.32e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CETP—obesity	3.58e-06	5.29e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ACACB—obesity	3.58e-06	5.29e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYTB—obesity	3.58e-06	5.29e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—OXCT1—obesity	3.58e-06	5.29e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—MTHFR—obesity	3.57e-06	5.27e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SDC1—obesity	3.56e-06	5.26e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—RHOA—obesity	3.55e-06	5.23e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SDC1—obesity	3.54e-06	5.23e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3R1—obesity	3.51e-06	5.18e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—NOS3—obesity	3.51e-06	5.18e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKR1C3—obesity	3.51e-06	5.17e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPARA—obesity	3.5e-06	5.17e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PNLIP—obesity	3.49e-06	5.15e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SRD5A1—obesity	3.49e-06	5.15e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKR1C3—obesity	3.49e-06	5.14e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SCARB1—obesity	3.45e-06	5.09e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SCARB1—obesity	3.43e-06	5.06e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SDC3—obesity	3.41e-06	5.03e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.4e-06	5.02e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AGT—obesity	3.39e-06	5.01e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CD—obesity	3.38e-06	4.99e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—ALB—obesity	3.36e-06	4.96e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SREBF1—obesity	3.35e-06	4.94e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CD—obesity	3.35e-06	4.94e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SREBF1—obesity	3.33e-06	4.92e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP26B1—obesity	3.33e-06	4.91e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—STS—obesity	3.33e-06	4.91e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HK2—obesity	3.33e-06	4.91e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOE—obesity	3.33e-06	4.91e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—ALB—obesity	3.31e-06	4.88e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—CAV1—obesity	3.29e-06	4.86e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—APOA1—obesity	3.29e-06	4.85e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GOT2—obesity	3.26e-06	4.81e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARD—obesity	3.26e-06	4.81e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GOT2—obesity	3.24e-06	4.78e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CB—obesity	3.24e-06	4.78e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.21e-06	4.74e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3R1—obesity	3.2e-06	4.72e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC27A1—obesity	3.19e-06	4.71e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—FASN—obesity	3.19e-06	4.71e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—BCHE—obesity	3.18e-06	4.69e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—FASN—obesity	3.17e-06	4.68e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3R1—obesity	3.16e-06	4.67e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—NOS3—obesity	3.16e-06	4.67e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—BCHE—obesity	3.16e-06	4.66e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism of lipids and lipoproteins—PIK3CA—obesity	3.15e-06	4.64e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—FABP4—obesity	3.13e-06	4.62e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GLUL—obesity	3.13e-06	4.62e-05	CbGpPWpGaD
Repaglinide—ALB—Platelet activation, signaling and aggregation—AKT1—obesity	3.13e-06	4.62e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP2E1—obesity	3.06e-06	4.52e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP2E1—obesity	3.05e-06	4.5e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NQO1—obesity	3.03e-06	4.47e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NQO1—obesity	3.01e-06	4.45e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CG—obesity	3e-06	4.43e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—UCP2—obesity	2.97e-06	4.38e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—UCP3—obesity	2.97e-06	4.38e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HSD11B1—obesity	2.97e-06	4.38e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ECHS1—obesity	2.97e-06	4.38e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.97e-06	4.38e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CB—obesity	2.95e-06	4.35e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.94e-06	4.34e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PTGS2—obesity	2.92e-06	4.31e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CB—obesity	2.92e-06	4.31e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ADH1B—obesity	2.92e-06	4.31e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GCG—obesity	2.9e-06	4.29e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—SLC2A4—obesity	2.9e-06	4.29e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PPARG—obesity	2.9e-06	4.27e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PTGS2—obesity	2.89e-06	4.27e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—SLC2A4—obesity	2.89e-06	4.26e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GCG—obesity	2.89e-06	4.26e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARGC1B—obesity	2.87e-06	4.24e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPAM—obesity	2.87e-06	4.24e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ACSL1—obesity	2.87e-06	4.24e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYCS—obesity	2.87e-06	4.23e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—POMC—obesity	2.86e-06	4.22e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYCS—obesity	2.85e-06	4.21e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—INS—obesity	2.84e-06	4.19e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GGT1—obesity	2.81e-06	4.15e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GOT1—obesity	2.81e-06	4.15e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GOT1—obesity	2.8e-06	4.13e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GGT1—obesity	2.8e-06	4.13e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—FADS1—obesity	2.79e-06	4.12e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HADH—obesity	2.79e-06	4.12e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PCK1—obesity	2.79e-06	4.12e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NCOA1—obesity	2.77e-06	4.09e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NCOA1—obesity	2.76e-06	4.07e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—STK11—obesity	2.73e-06	4.03e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CYP19A1—obesity	2.73e-06	4.03e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CYP19A1—obesity	2.72e-06	4.01e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—STK11—obesity	2.72e-06	4.01e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ACP5—obesity	2.71e-06	4.01e-05	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—MYC—obesity	2.7e-06	3.98e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—G6PD—obesity	2.65e-06	3.9e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CD—obesity	2.64e-06	3.89e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HK1—obesity	2.61e-06	3.86e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SREBF2—obesity	2.61e-06	3.86e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—ALB—obesity	2.6e-06	3.84e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—COMT—obesity	2.54e-06	3.75e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—COMT—obesity	2.52e-06	3.73e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LPA—obesity	2.52e-06	3.72e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GNB3—obesity	2.5e-06	3.69e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPARGC1A—obesity	2.5e-06	3.69e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—HMOX1—obesity	2.49e-06	3.68e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—NOS3—obesity	2.49e-06	3.68e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3R1—obesity	2.49e-06	3.68e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GNB3—obesity	2.49e-06	3.67e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPARGC1A—obesity	2.49e-06	3.67e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—PIK3CA—obesity	2.48e-06	3.67e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—HMOX1—obesity	2.48e-06	3.66e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LPIN1—obesity	2.47e-06	3.64e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GNAS—obesity	2.44e-06	3.6e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GNAS—obesity	2.42e-06	3.58e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOA5—obesity	2.42e-06	3.57e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—PIK3CA—obesity	2.41e-06	3.55e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOB—obesity	2.39e-06	3.52e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOB—obesity	2.37e-06	3.5e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—TGFB1—obesity	2.32e-06	3.43e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CLOCK—obesity	2.31e-06	3.41e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC22A1—obesity	2.31e-06	3.41e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CB—obesity	2.3e-06	3.39e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—LPL—obesity	2.28e-06	3.36e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PTGS2—obesity	2.28e-06	3.36e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—LPL—obesity	2.27e-06	3.34e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SULT2A1—obesity	2.25e-06	3.32e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GLP1R—obesity	2.25e-06	3.32e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—GPX1—obesity	2.22e-06	3.28e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—DPYD—obesity	2.21e-06	3.27e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—GPX1—obesity	2.21e-06	3.26e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CD36—obesity	2.17e-06	3.2e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CD36—obesity	2.15e-06	3.18e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PRKAR2B—obesity	2.13e-06	3.14e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—DCN—obesity	2.11e-06	3.12e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CPT1A—obesity	2.06e-06	3.04e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—MTHFR—obesity	2.05e-06	3.03e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—MTHFR—obesity	2.04e-06	3.01e-05	CbGpPWpGaD
Repaglinide—ABCC8—Metabolism—AKT1—obesity	2.03e-06	2.99e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NAMPT—obesity	2.02e-06	2.98e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPARA—obesity	2.01e-06	2.97e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GCK—obesity	2e-06	2.96e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LIPC—obesity	2e-06	2.96e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPARA—obesity	2e-06	2.95e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOC3—obesity	1.99e-06	2.94e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—PIK3CA—obesity	1.98e-06	2.92e-05	CbGpPWpGaD
Repaglinide—KCNJ11—Metabolism—AKT1—obesity	1.97e-06	2.9e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AGT—obesity	1.95e-06	2.88e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AGT—obesity	1.94e-06	2.86e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CETP—obesity	1.93e-06	2.85e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SDC1—obesity	1.91e-06	2.82e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOE—obesity	1.91e-06	2.82e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOE—obesity	1.9e-06	2.8e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—CAV1—obesity	1.89e-06	2.79e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—APOA1—obesity	1.89e-06	2.79e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—CAV1—obesity	1.88e-06	2.78e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKR1C3—obesity	1.88e-06	2.78e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—APOA1—obesity	1.88e-06	2.77e-05	CbGpPWpGaD
Repaglinide—PPARG—Gene Expression—AKT1—obesity	1.87e-06	2.76e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SCARB1—obesity	1.85e-06	2.73e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.81e-06	2.67e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism of lipids and lipoproteins—PIK3CA—obesity	1.8e-06	2.65e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SREBF1—obesity	1.8e-06	2.65e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—PIK3CA—obesity	1.78e-06	2.63e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GOT2—obesity	1.75e-06	2.58e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CG—obesity	1.72e-06	2.54e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CG—obesity	1.71e-06	2.53e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—FASN—obesity	1.71e-06	2.53e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—BCHE—obesity	1.7e-06	2.52e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PPARG—obesity	1.66e-06	2.46e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PPARG—obesity	1.65e-06	2.44e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP2E1—obesity	1.64e-06	2.43e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—POMC—obesity	1.64e-06	2.42e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—INS—obesity	1.63e-06	2.41e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—POMC—obesity	1.63e-06	2.41e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NQO1—obesity	1.63e-06	2.4e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—INS—obesity	1.62e-06	2.4e-05	CbGpPWpGaD
Repaglinide—ALB—Hemostasis—AKT1—obesity	1.61e-06	2.38e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GCG—obesity	1.56e-06	2.3e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—SLC2A4—obesity	1.56e-06	2.3e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYCS—obesity	1.54e-06	2.27e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CD—obesity	1.52e-06	2.24e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GGT1—obesity	1.51e-06	2.23e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GOT1—obesity	1.51e-06	2.23e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CD—obesity	1.51e-06	2.22e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—ALB—obesity	1.5e-06	2.21e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NCOA1—obesity	1.49e-06	2.2e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—STK11—obesity	1.47e-06	2.16e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CYP19A1—obesity	1.47e-06	2.16e-05	CbGpPWpGaD
Repaglinide—PPARG—Metabolism—AKT1—obesity	1.45e-06	2.15e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—NOS3—obesity	1.43e-06	2.11e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3R1—obesity	1.43e-06	2.11e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—NOS3—obesity	1.42e-06	2.1e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3R1—obesity	1.42e-06	2.1e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—PIK3CA—obesity	1.4e-06	2.07e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—COMT—obesity	1.36e-06	2.01e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GNB3—obesity	1.34e-06	1.98e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARGC1A—obesity	1.34e-06	1.98e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—HMOX1—obesity	1.34e-06	1.97e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CB—obesity	1.32e-06	1.95e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CB—obesity	1.31e-06	1.94e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PTGS2—obesity	1.31e-06	1.93e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GNAS—obesity	1.31e-06	1.93e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PTGS2—obesity	1.3e-06	1.92e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOB—obesity	1.28e-06	1.89e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—LPL—obesity	1.22e-06	1.81e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—GPX1—obesity	1.19e-06	1.76e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CD36—obesity	1.16e-06	1.72e-05	CbGpPWpGaD
Repaglinide—SLCO1B1—Metabolism—AKT1—obesity	1.15e-06	1.69e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—MTHFR—obesity	1.1e-06	1.63e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARA—obesity	1.08e-06	1.59e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AGT—obesity	1.05e-06	1.54e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOE—obesity	1.03e-06	1.51e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—CAV1—obesity	1.02e-06	1.5e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—APOA1—obesity	1.01e-06	1.5e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CG—obesity	9.26e-07	1.37e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PPARG—obesity	8.93e-07	1.32e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—POMC—obesity	8.81e-07	1.3e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—INS—obesity	8.76e-07	1.29e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CD—obesity	8.14e-07	1.2e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—PIK3CA—obesity	8.05e-07	1.19e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—ALB—obesity	8.03e-07	1.19e-05	CbGpPWpGaD
Repaglinide—ALB—Metabolism—PIK3CA—obesity	8.01e-07	1.18e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—NOS3—obesity	7.68e-07	1.13e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3R1—obesity	7.68e-07	1.13e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CB—obesity	7.09e-07	1.05e-05	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PTGS2—obesity	7.03e-07	1.04e-05	CbGpPWpGaD
Repaglinide—CYP2C8—Metabolism—AKT1—obesity	6.58e-07	9.71e-06	CbGpPWpGaD
Repaglinide—ALB—Metabolism—AKT1—obesity	6.54e-07	9.66e-06	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—PIK3CA—obesity	4.32e-07	6.38e-06	CbGpPWpGaD
Repaglinide—CYP3A4—Metabolism—AKT1—obesity	3.53e-07	5.21e-06	CbGpPWpGaD
